Sage Journals: Discover world-class research

Abstract

Background

Expenditure on research and development is a macroeconomic indicator representative of national investment. International organizations use this indicator to compare international research and development activities.

Aim

We investigated whether differences in expenditures on research and development at the country level may influence the incidence of stroke and stroke mortality.

Methods

We compared stroke metrics with absolute amount of gross domestic expenditure on R&D (GERD) per-capita adjusted for purchasing power parity (aGERD) and relative amount of GERD as percent of gross domestic product (rGERD). Sources included official data from the UNESCO, the World Health Organization, the World Bank, and population-based studies. We used correlation analysis and multivariable linear regression modeling.

Results

Overall, data on stroke mortality rate and GERD were available from 66 countries for two periods (2002 and 2008). Age-standardized stroke mortality rate was associated with aGERD (r = −0.708 in 2002 and r = −0.730 in 2008) or rGERD (r = −0.545 in 2002 and r = −0.657 in 2008) (all p < 0.001). Multivariable analysis showed a lower aGERD and rGERD were independently and inversely associated with higher stroke mortality (all p < 0.05). The estimated prevalence of hypertension, diabetes, or obesity was higher in countries with lower aGERD. The analysis of 27 population-based studies showed consistent inverse associations between aGERD or rGERD and incident risk of stroke and 30-day case fatality.

Conclusions

There is higher stroke mortality among countries with lower expenditures in research and development. While this study does not prove causality, it suggests a potential area to focus efforts to improve global stroke outcomes.

Keywords

Ischemic stroke outcome epidemiology research and development

Get full access to this article

View all access options for this article.

References

Murray

CJL

Vos

Lozano

et al.

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197–2223.

GBD 2013 Mortality and Causes of Dath Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385: 117–171.

World Health Organization. WHO. WHO Health statistics and information systems, http://www.who.int/healthinfo/global_burden_disease/en/ (assessed 10 August 2015).

Battelle Technology Partnership Practice. Economic impact of the Human Genome Project, www.battelle.org/spotligght/5-11-11_grnomr.aspx 2011 (assessed 7 April 2016).

Meo

Al Masri

Usmani

Memon

Zaidi

. Impact of GDP, spending on R&D, number of universities and scientific journals on research publications among Asian countries. PLoS One 2013; 8: e66449.

Rochon

du Bois

. Clinical research in epithelial ovarian cancer and patients’ outcome. Ann Oncol 2011; 22: vii16–vii19.

Laliberte

Fennell

Papandonatos

. The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer. Med Care 2005; 43: 471–479.

Hanney

Boaz

Jones

Soper

. Engagement in research: an innovative three-stage review of the benefits for health-care performance. Health Serv Deliv Res 2013; 1: 51–64.

OECD. Frascati manual 2015, guidelines for collecting and reporting data on research and experimental development. The measurement of scientifc, technological and innovation activities, Paris: OECD Publishing, 2015.

10.

UNESCO. UNESCO Institute for Statistics, http://data.uis.unesco.org/Index.aspx? (assessed 10 November 2015).

11.

World Health Organization. Causes of death 2008: data sources and methods. Geneva: World Health Organization, http://www.who.int/healthinfo/global_burden_disease/cod_2008_sources_methods.pdf (2010, accessed 29 October, 2015).

12.

World Health Organization. WHO Global Health Observatory data repository, http://apps.who.int/gho/data/node.imr (assessed 10 August 2015).

13.

The World Bank, http://data.worldbank.org/indicator/ (assessed 10 November 2015).

14.

World Bank. The Little Green Data Book 2015, Washington, DC: World Bank, 2015.

15.

Cutler

Sirkanth

. The economics of better health: the case of cardiovascular disease, Cambridge: Harvard University, 1999.

16.

Access Economics. Exceptional returns: the value of investing in health R&D in Australia II. Canberra: Australian Society for Medical Research, 2008.

17.

Sharyl

Laura

Lawrence

. Beyond the HIPAA privacy rule: enhancing privacy, improving health through research, Washington, DC: National Academies Press, 2009.

18.

Meo

Usmani

. Impact of R&D expenditures on research publications, patents and high-tech exports among European countries. Eur Rev Med Pharmacol Sci 2014; 18: 1–9.

19.

Rottingen

Regmi

Eide

et al.

Mapping of available health research and development data: what’s there, what’s missing, and what role is there for a global observatory?

Lancet 2013; 382: 1286–1307.

20.

Ozdemir

Karthikesalingam

Sinha

et al.

Research activity and the association with mortality. PLoS One 2015; 10: e0118253.

21.

Bullock

Morris

Atwell

. Collaboration between health services managers and researchers: making a difference? J Health Serv Res Policy 2012; 17: 2–10.

22.

Christmas

Durso

Kravet

Wright

. Advantages and challenges of working as a clinician in an academic department of medicine: academic clinicians’ perspectives. J Grad Med Educ 2010; 2: 478–484.

23.

Goyal

Menon

van Zwam

et al.

Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016; 387: 1723–1731.

24.

O’Donnell

Chin

Rangarajan

et al.

Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 2016; 388: 761–775.

25.

Strong

Mathers

Bonita

. Preventing stroke: saving lives around the world. Lancet Neurol 2007; 6: 182–187.

26.

Kroll

Phalkey

Kraas

. Challenges to the surveillance of non-communicable diseases – a review of selected approaches. BMC Public Health 2015; 15: 1243.

27.

Nam

Park

Heo

. Facilitating stroke management using modern information technology. J Stroke 2013; 15: 135–143.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.27 MB

Does national expenditure on research and development influence stroke outcomes?

Abstract

Background

Aim

Methods

Results

Conclusions

Keywords

Get full access to this article

References

Supplementary Material